Updated:
Saving Sight
Saving Sight is a nonprofit organization founded in 1960 in Kansas City, Missouri. It provides solutions to clinical partners and facilitates eye donation...
Saving Sight
Saving Sight is a nonprofit organization founded in 1960 in Kansas City, Missouri. It provides solutions to clinical partners and facilitates eye donation through transplantation. Saving Sight made a single investment in Brightstar Therapeutics as part of its Series A on April 18, 2023.
General information
Firm type
Foundation
Location
Region
North America
Country
United States
City
Minneapolis
Corporate office
Minneapolis, MN, United States
Principals
Annie M. Krapek
President & CEO
Sector focus
Frequently asked questions
What is Saving Sight's primary operational model — is it a grantmaker or a direct service provider?
Saving Sight is primarily a direct service provider. It operates a full-service eye bank that recovers, evaluates, and distributes donor corneal tissue for transplant surgery. Alongside this clinical function, it runs community vision programs — such as mobile eye clinics that offer free exams and glasses — and provides targeted grants to residency programs and safety-net eye clinics. It is not a health-conversion foundation that simply administers a grantmaking portfolio.
How did the April 2024 merger with VisionFirst change the organization's geographic footprint?
Before the merger, Saving Sight's primary service area covered Missouri, Kansas, and parts of Illinois, with a growing presence in Minnesota. VisionFirst brought service relationships in central Indiana and Kentucky. The combined entity now coordinates eye-banking and community vision work across five states, with laboratory and administrative offices in Minneapolis, Kansas City, Columbia (MO), Springfield (MO), and Indianapolis.
Does Saving Sight fund or conduct ophthalmic research?
Yes. The organization allocates tissue for research purposes in addition to transplant use, and it has historically funded clinical studies, residency training programs, and fellowships in cornea and external disease. Research funding decisions are made internally and are typically linked to its mission of improving cornea-transplant outcomes and expanding access to eye care.
Who governs Saving Sight and how is its board constituted?
Saving Sight is governed by a volunteer board of directors, historically drawn from ophthalmologists, Lions Clubs International members, and community leaders in the regions it serves. The board sets strategic direction for both the eye-bank operations and the community-outreach mission, and it appoints the President and CEO.
Is Saving Sight affiliated with the Lions Clubs, and does that affect its funding?
The organization was originally founded as a Lions eye bank and retains a close operational and governance tie to Lions Clubs in Missouri and its other service states. While Lions Clubs provide volunteer support and community fundraising, the majority of Saving Sight's operating revenue comes from tissue-processing fees paid by hospitals and surgical centers, not from Lions dues. This relationship is a governance and volunteer pipeline, not a primary funding mechanism.
What is Saving Sight's known posture toward partnerships with for-profit ophthalmology or biotech firms?
Saving Sight partners selectively with for-profit entities, principally for tissue placement, surgical training, and research. It has supply relationships with device manufacturers and occasionally participates in clinical studies alongside industry sponsors, but it operates as a mission-driven nonprofit and does not take equity positions or venture-capital-style stakes in partner companies.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on endowments & foundations?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: